Navigation Links
Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Date:8/13/2013

LOUISVILLE, Ky., Aug. 13, 2013 /PRNewswire-iReach/ -- In collaboration with the James Graham Brown Cancer Center at the University of Louisville, LBIdx™ is advancing a breakthrough blood test, the Plasma Thermogram™ (pT). Based on a simple blood draw, researchers at LBIdx™ and the Brown Cancer Center see great promise for the pTtest as a "game-changer" allowing physicians to monitor cancer patients more closely. Monitoring is a critical part of cancer treatment and provides physicians with vital information in the fight against cancer.

LBIdx™ and the Brown Cancer Center are initiating a clinical study that will demonstrate the pT test's capabilities for improved monitoring of melanoma patients at dangerous risk of metastasis and for response to medical treatment. Director Donald Miller M.D., Ph.D. and Deputy Director Jason A. Chesney, M.D., Ph.D., will be co-investigators of the planned study to detect earlier signs of change in disease status. Researchers expect the pTwill provide a unique insight into cancer status leading to improved medical response options, including therapy. Equally important, this test stands to be an earlier indicator or remission or relapse.  In all, the test stands to help answer those age-old questions, "Am I winning my battle with cancer?" and "Is my cancer gone?" 

Current medical practice frequently relies on medical imaging procedures, like CT scans, to monitor melanoma patients. But due to the high dose radiation exposure from each procedure, their use by physicians is limited, which can hinder patient monitoring.  In addition, the FDA is striving to reduce unnecessary radiation exposure from these medical imaging procedures which are the greatest contributors to total radiation exposure within the U.S.

Alfred "Ben" Jenson, Professor of Vaccinology at the James Graham Brown Cancer Center and co-inventor of the pThas been a strong supporter of the pT's cancer monitoring potential.  Ben is also known for his work as co-inventor of the cervical cancer vaccine, Gardasil, and sees potential for the pT as a monitoring tool for a multitude of cancers, including difficult-to-detect oral cancers.

LBIdx™ is a start-up company, focused on the commercialization of pT tests for cancer monitoring and prognosis. It is currently raising funds via a crowd funding campaign allowing the public, who will benefit from such a test, to support this enhanced cancer monitoring effort. Crowd funding is a relatively new concept approved by the U.S. Jobs Act of 2012. Details of their 'Breakthrough in Cancer Detection & Monitoring' campaign can be found on the Indiegogo crowd funding website using the following link, http://igg.me/at/CancerDetectionStudy.

About Louisville Bioscience, Inc.

LBIdx™, headquartered in Louisville, Kentucky, is a start-up company with an exclusive license to the University of Louisville Plasma Thermogram™ (pT) technology and focused on the commercialization of pT tests for cancer monitoring and prognosis.  The novel pT blood test can provide earlier detection of disease, effectively assess status of cancer remission and improve monitoring in response to therapy for numerous cancers including: melanoma, breast, cervical, ovarian and lung cancers. The pT diagnostic platform utilizes Differential Scanning Calorimetry (DSC) to generate a robust temperature-induced melting profile of the major blood proteins. The LBIdx™ core technology was invented by the University of Louisville team of Dr. Jonathan Chaires (James Graham Brown Endowed Chair of Cancer Biophysics), Dr. Nichola Garbett and Dr. Alfred "Ben" Jenson. For more information, please visit www.lbidx.com

Media Contact: Michael Birdsell, LBIdx, 502.414.1243, mbirdsell@lbidx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE LBIdx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
2. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
3. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Helping Start-Ups Avoid Slow-Downs
6. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
7. $1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
8. American Academy of Pain Medicine Reacts to PROP Petition to the FDA that Seeks to Limit Pain Medications for Legitimate Noncancer Pain Sufferers
9. Searcy Denney Scarola Barnhart & Shipley PA Seeks Damages Caused by Recalled Product
10. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
11. Prosum Kicks Off Crowd Funding for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... 6, 2017 Eli Lilly and Company (NYSE: ... new data for galcanezumab and lasmiditan, two investigational treatments ... Headache Society (IHC) taking place Sept. 7-10 in ... highlight new, long-term data from an open-label study evaluating ... (120 mg and 240 mg) for the prevention of ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the latest ... Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... include new preclinical and clinical data on Bayer,s marketed portfolio ... pipeline projects. "We ... minds in cancer research at ESMO," said Carsten Brunn ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... , ... On Sunday, September 24, hundreds will gather at Flo Jo Park ... the fastest woman of all time. Flo Jo passed away from complications related ... National Anthem. Mary was a contestant on the 2012 season of America’s Got ...
(Date:9/22/2017)... ... September 22, 2017 , ... Fenwick Agency of Plano, TX has announced the ... part of the nationally recognized ‘Agents of Change’ movement. The agency pledges to select ... leaders to seek out those who most need help. Their hope is to bring ...
(Date:9/22/2017)... ... September 22, 2017 , ... After ... a senior finds a new lease on life with assistance from CreditAssociates. CreditAssociates ... resolve their problem with unsecured debt. The senior is one of the satisfied ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... IL (PRWEB) , ... September 22, 2017 , ... Pullano ... attorney Richard L. Pullano has been selected to serve as President of ... 50th President at the Installation and Award Dinner hosted by the NSBA at the ...
Breaking Medicine News(10 mins):